Magnesium Sulfate Kalceks

Magnesium sulfate, the active ingredient in Magnesium Sulfate Kalceks, is a magnesium salt presented as an injection solution for intramuscular and intravenous use. It is employed to replace magnesium electrolytes and to manage conditions such as eclampsia, severe preeclampsia, magnesium deficiency, torsades de pointes, and asthma exacerbation.

GNH USA supplies Magnesium Sulfate Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnesium sulfate is used in obstetric, cardiac and respiratory care to correct magnesium deficiency and related disorders. - Eclampsia: prevents and controls seizures in pregnant women with this condition. - Severe preeclampsia: stabilises blood pressure and reduces risk of convulsions. - Magnesium deficiency: restores normal serum magnesium levels. - Torsades de pointes: terminates this ventricular tachyarrhythmia. - Asthma exacerbation: relaxes bronchial smooth muscle to improve airflow.

Adverse reactions may occur with magnesium sulfate administration.

Common Side Effects: - Flushing or feeling of warmth. - Nausea or vomiting. - Hypotension. - Muscle weakness or fatigue. - Headache.

Serious or Rare Side Effects: - Respiratory depression or arrest. - Severe hypotension leading to shock. - Cardiac arrhythmias, including heart block. - Hypermagnesemia with neurological impairment. - Anaphylactic or severe allergic reactions.

Magnesium sulfate requires careful monitoring and specific safety measures. - Serum magnesium monitoring: check levels before and during therapy. - Renal impairment: adjust dose or avoid rapid infusion. - Cardiac conduction disorders: avoid in patients with heart block. - Neuromuscular disease: use cautiously in myasthenia gravis. - Concomitant neuromuscular blockers: may potentiate effects. - Store at controlled room temperature: keep in original container, protect from light and moisture.

Magnesium sulfate can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Calcium channel blockers: additive vasodilatory effect may cause severe hypotension. - Other magnesium‑containing products: risk of hypermagnesemia. - Aminoglycoside antibiotics: increased risk of neuromuscular blockade.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor blood pressure and renal function. - Loop or thiazide diuretics: may affect magnesium balance. - Anticoagulants: monitor for bleeding if high doses are used.